SOD1 and amyotrophic lateral sclerosis: Tofersen, an antisense oligonucleotide, reduces oxidative stress by lowering the expression of mutant SOD1 protein and has been used in amyotrophic lateral sclerosis (ALS) treatment [185]. However, its role in cancer treatment remains to be explored.